СОБСТВЕННЫЙ ОПЫТ ПРИМЕНЕНИЯ КОМБИНАЦИИ БЕВАЦИЗУМАБ + ИНТЕРФЕРОН -2А У БОЛЬНЫХ ДИССЕМИНИРОВАННЫМ ПОЧЕЧНО-КЛЕТОЧНЫМ РАКОМ
https://doi.org/10.17650/1726-9776-2010-6-4-32-35
Аннотация
Об авторах
А. М. ПоповРоссия
О. Б. Карякин
Россия
Н. А. Горбань
Россия
Список литературы
1. Motzer R.J., Bacik J., Murphy B.A. et al. Interferon-alfa as a comparative treatment for clinical trials of new therapies againstadvanced renal cell carcinoma. J Clin Oncol 2002;20(1):289–96.
2. Escudier B., Pluzanska A., Koralewski P. et al. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. Lancet 2007;370:2103–11.
3. Escudier B., Bellmunt J., Negrier S. et al. Phase III trial of bevacizumab plus interferon alfa-2A in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall surviva. J Clin Oncol 2010;28:2144–50.
4. Melichar B., Koralewski P., Ravaud A. et al. First-line bevacizumab combined with reduced dose interferon-a2a is active in patients with metastatic renal cell carcinoma. Ann of Oncol 2008;19(8):1470–6.
5. Flanigan R.C., Salmon S.E., Blumenstein B.A. et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 2001;345(23):1655–9.
6. Mickisch G.H., Garin A., van Poppel H. et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 2001;22;358 (9286):966–70.
7. Dham A., Dudek A. Sequential therapy with sorafenib and sunitinib in renal cell carcinoma. ASCO 2007;abstr 5106.
8. Sablin M., Bouaita L., Balleyguier C. et al. Sequential use of sorafenib and sunitinib in renal cancer: Retrospective analysis in 90 patients. ASCO 2007;abstr 5038.
9. Rini B.I., Michaelson M.D., Rosenberg J.E. et al. Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma. J Clin Oncol 2008;26:3743–8.
Рецензия
Для цитирования:
Попов А.М., Карякин О.Б., Горбань Н.А. СОБСТВЕННЫЙ ОПЫТ ПРИМЕНЕНИЯ КОМБИНАЦИИ БЕВАЦИЗУМАБ + ИНТЕРФЕРОН -2А У БОЛЬНЫХ ДИССЕМИНИРОВАННЫМ ПОЧЕЧНО-КЛЕТОЧНЫМ РАКОМ. Онкоурология. 2010;6(4):32-35. https://doi.org/10.17650/1726-9776-2010-6-4-32-35
For citation:
Popov A.M., Karyakin O.B., Gorban N.A. THE AUTHOR’S EXPERIENCE IN USING BEVACIZUMAB PLUS INTERFERON ALFA-2A IN PATIENTS WITH DISSEMINATED RENAL CELL CARCINOMA. Cancer Urology. 2010;6(4):32-35. (In Russ.) https://doi.org/10.17650/1726-9776-2010-6-4-32-35